Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Oxprofen (Ibuprofen-LDH) in Healthy Adults
NCT02974361Phase 1Completed
- Sponsor
- Oxford Pharmascience
- Start
- Dec 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oxprofen in myalgia, Headache and fever (17 arms), sponsored by Oxford Pharmascience. Primary endpoints: Maximum Plasma Concentration at 12 hours and Area Under the Curve at 12 hours. Started Dec 2016; status: completed.
02
Drugs
oxprofen
03
Conditions
myalgiaHeadachefever
Beyond the preview
Go deeper on NCT02974361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02974361.